How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting von Sehouli, Jalid, Boer, Jolijn, Brand, Alison H, Oza, Amit M, O'Donnell, Jennifer, Bennett, Katherine, Glaspool, Ros, Lee, Chee Khoon, Ethier, Josee-Lyne, Harter, Philipp, Seebacher-Shariat, Veronika, Chang, Ting-Chang, Cohen, Paul A, van Gorp, Toon, Chavez-Blanco, Adriana, Welch, Stephen, Hranovska, Hanna, O'Toole, Sharon, Lok, Christianne A.R, Madariaga, Ainhoa, Rauh-Hain, Jose Alejandro, Perez Fidalgo, Alejandro, Tan, David, Michels, Judith, Pothuri, Bhavana, Fujiwara, Noriko, Rosengarten, Ora, Nishio, Hiroshi, Kim, Se Ik, Mukopadhyay, Asima, Piovano, Elisa, Cecere, Sabrina Chiara, Kohn, Elise C, Mukherjee, Uma, Nasser, Sara, Lindemann, Kristina, Croke, Jennifer, Chen, Xiaojun, Geissler, Franziska, Bookman, Michael A

Volltext